[1] EZIKE TC, OKAPALA US, ONOJA UL, et al.Advances in Drug Delivery Systems, Challenges and Future Directions[J]. Heliyon, 2023, 9(6): 17. [2] MEYER RJ, HUSSAIN AS. Mitigating the Risks of Ethanol Induced Dose Dumping from Oral Sustained/Controlled Release Dosage Forms[EB/OL]. (2005-10-26)[2025-12-20]. https://www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4187B1_01. [3] KUMAR S, MAHESHWARI D.Regulatory Expectations and Challenges in Alcohol-Induced Dose Dumping: a Review[J]. Dissolution Technologies, 2025, 32(2): 76-80. [4] FDA. Guidance for Industry: Bioavailability Studies Submitted in NDAs or INDs—General Considerations[EB/OL]. (2022-04-15)[2025-12-20]. https://www.fda.gov/media/121311/download. [5] EMA. Guideline on the Pharmacokinetic and Clinical Evaluation of Modified Release Dosage Forms[EB/OL]. (2014-11-20)[2025-12-20]. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmacokinetic-and-clinical-evaluation-modified-release-dosage-forms_en. [6] ARMSTRONG K, BERGER A.What Counts as a Drink? Understanding Standard Drink Equivalence and US Dietary Guidelines for Alcohol[J]. Current Developments in Nutrition, 2022, 6(1): 871. [7] CDE, NMPA. Technical Guidelines for Pharmaceutical Research on Ethanol Dose Dumping of Chemical Generic Oral Modified Release Preparations[EB/OL]. (2022-11-08)[2025-12-20]. https://www.cde.org.cn/main/news/viewInfoCommon/cd0b414826862271694b629472e3964c. [8] DUAN LP, CHEN XX, YANG Z, et al.Preparation and in vitro-in vivo Evaluation of Aspirin Enteric-Coated Tablets[J]. Journal of Kunming Medical University(昆明医科大学学报), 2024, 45(6): 69-74. [9] ZHOU JH, LI N, LI X, et al.Review on Recent Advancements in Understanding Acetylsalicylic Acid-Induced Gastrointestinal Injury: Mechanisms, Medication and Dosage Refinement[J]. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2025, 398(4): 3297-3320. [10] MASUTANI N, OGAWA H, SOEJIMA H, et al.Long-Term Effects of Low-Dose Aspirin on Gastrointestinal Symptoms and Complications in Patients With Type 2 Diabetes[J]. Am J Cardiovasc Drugs, 2025, 25: 95-112. [11] SIDLAK AM, SPADARO A, KOYFMAN A, et al.Acute Salicylate Toxicity: a Narrative Review for Clinicians[J]. Cureus, 2025, 17(9): e91505. [12] ROWE PH, STARLING MJ, KASDON E, et al.Parenteral Aspirin and Sodium Salicylate Are Equally Injurious to the Rat Gastric Mucosa[J]. Gastroenterology, 1987, 93(4): 863-871. [13] SU H, ZAN MQ, NIU JZ, et al.Effect of Ethanol on in vitro Release Behavior of Glipizide Controlled-Release Tablets Determined by HPLC[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2024, 21(6): 638-643, 650. [14] JI M, SWARNAKAR NK, CHALAMURI SH, et al.Development of Alcohol-Resistant Extended-Release Formulations: Regulatory Considerations and Formulation Strategies[J]. Pharmaceutical Research, 2025, 42(12): 2223-2234. [15] LECOMTE F, SIEPMANN J, WALTHER M, et al.Polymer Blends for Multiparticulate Coatings: Comparison of Aqueous and Organic Coating Techniques[J]. Pharmaceutical Research, 2004, 21(5): 882-890. [16] ROBERTS M, CESPI M, FORD JL, et al.Influence of Ethanol on Aspirin Release from Hypromellose Matrices[J]. Int J Pharm, 2007, 332(1-2): 31-37. [17] JEDINGER N, KHINAST J, ROBLEGG E.Design of Controlled Release Formulations Resistant to Alcohol-Induced Dose Dumping: a Review[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2014, 87(1): 217-226. [18] CHEN K, CHANG HHR, LUGTU-PE J, et al.Exploration of a Novel Terpolymer Nanoparticle System for Prevention of Alcohol-Induced Dose Dumping[J]. Molecular Pharmaceutics, 2024, 21(12): 6257-6269. |